AHPA OmniAb Inc


$ 1.67 $ -0.04 (-2.35 %)    

Friday, 17-Oct-2025 15:59:58 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 1.66
$ 1.68
$ 1.63 x 1,000
$ 1.83 x 10,000
$ 1.64 - $ 1.72
$ 1.22 - $ 4.87
226,622
na
na
$ 1.60
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-pinterest-shares-jumped-around-14-here-are-69-biggest-movers-from-friday

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.

 why-edwards-lifesciences-shares-are-trading-lower-by-around-17-here-are-47-stocks-moving-in-fridays-mid-day-session

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301.

Core News & Articles

First FDA approval of a bispecific antibody discovered using OmniAb technology OmniAb, Inc. is eligible to receive a $25 milli...

Core News & Articles

APAC Shareholder Approval Obtained, Closing Scheduled for November 1, 2022 Ligand "Regular Way" and "Ex-Distributi...

Core News & Articles

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that its board of directors has set October 26, 2022 as the r...

 the-daily-biotech-pulse-novartis-prostate-cancer-drug-lands-fda-approval-ligand-announces-spac-deal-to-spin-off-antibody-business-lillys-lung-cancer-therapy-hit-with-crl

Here's a roundup of top developments in the biotech space over the last 24 hours:

 ligand-to-spin-off-omniab-via-avista-capital-backed-spac-merger

Ligand Pharmaceuticals Inc (NASDAQ: LGND) 

Core News & Articles

Ligand Pharmaceuticals Incorporated (Ligand) (NASDAQ:LGND) today announced the signing of a definitive merger agreement with Av...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION